These success, along with a preceding report showing that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like actions in mice,2 support the idea of targeting ACKR3 as a novel strategy to modulate the opioid system, which could open new therapeutic avenues for opioid-associated Conditions.Healthful joints allow us to move without difficul